[1]
Hultman, B. et al. 2012. Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer. Acta Oncologica. 51, 1 (Jan. 2012), 112–121. DOI:https://doi.org/10.3109/0284186X.2011.594809.